Theyve basically said, look, we understand we want to build the future, and we dont just want the future be built on top of us
Three potency failures, and one odd label choice Of the three outright failures to match label claim, one product came in at 80% and another at 55%
Cell Host Microbe 22 , 207216 (2017)
This evidence-based guide examines: The pharmacology and mechanism of GLP-1 receptor agonists Whether delayed gastric emptying affects nutrient absorption How sustained appetite suppression may alter micronutrient density Protein intake and lean mass preservation during rapid weight loss Nutrients of potential concern (iron, vitamin B12, folate, magnesium, calcium, vitamin D, fat-soluble vitamins, electrolytes and zinc) Clinical monitoring strategies and laboratory markers Dietary and supplementation considerations grounded in current evidence Current literature does not support the claim that GLP-1 medications universally cause micronutrient deficiencies
Simply put, it mirrors the effects of a naturally occurring hormone that orchestrates blood sugar levels and appetite
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist, which means it mimics the effects of a hormone called GLP-1